CY1115916T1 - Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου - Google Patents
Αντιβιοτικες συνθεσεις για θεραπεια του αυτιουInfo
- Publication number
- CY1115916T1 CY1115916T1 CY20151100023T CY151100023T CY1115916T1 CY 1115916 T1 CY1115916 T1 CY 1115916T1 CY 20151100023 T CY20151100023 T CY 20151100023T CY 151100023 T CY151100023 T CY 151100023T CY 1115916 T1 CY1115916 T1 CY 1115916T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compositions
- antibiotic compositions
- early therapy
- ophthalmic
- nasal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Αποκαλύπτονται οφθαλμολογικές, ωτιαίες και ρινικές συνθέσεις περιέχοντας μία νέα κατηγορία αντιβιοτικών (π.χ. μοξιφλοξασίνη). Οι συνθέσεις περιέχουν ακόμα κατά προτίμηση ένα ή περισσότερους αντιφλεγμονώδεις παράγοντες. Οι συνθέσεις μπορούν να χρησιμοποιηθούν για να θεραπεύσουν οφθαλμολογικές, ωτιαίες και ρινικές παθήσεις με τη τοπική εφαρμογή των συνθέσεων στους νοσούντες ιστούς.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10250498P | 1998-09-30 | 1998-09-30 | |
US10250698P | 1998-09-30 | 1998-09-30 | |
EP10176412.4A EP2269602B1 (en) | 1998-09-30 | 1999-09-29 | Antibiotic compositions for treatment of the ear |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115916T1 true CY1115916T1 (el) | 2017-01-25 |
Family
ID=26799441
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111100409T CY1111404T1 (el) | 1998-09-30 | 2011-04-21 | Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου |
CY20141100819T CY1115759T1 (el) | 1998-09-30 | 2014-10-09 | Αντιβιοτικες συνθεσεις για θεραπεια του οφθαλμου |
CY20151100023T CY1115916T1 (el) | 1998-09-30 | 2015-01-09 | Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111100409T CY1111404T1 (el) | 1998-09-30 | 2011-04-21 | Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου |
CY20141100819T CY1115759T1 (el) | 1998-09-30 | 2014-10-09 | Αντιβιοτικες συνθεσεις για θεραπεια του οφθαλμου |
Country Status (18)
Country | Link |
---|---|
EP (5) | EP1384478B1 (el) |
JP (5) | JP2002525317A (el) |
KR (1) | KR101463243B1 (el) |
CN (2) | CN100374114C (el) |
AR (2) | AR020661A1 (el) |
AT (2) | ATE501732T1 (el) |
AU (1) | AU762827B2 (el) |
BR (1) | BRPI9914151B1 (el) |
CA (3) | CA2659064A1 (el) |
CY (3) | CY1111404T1 (el) |
DE (2) | DE69912972T2 (el) |
DK (5) | DK2796138T3 (el) |
ES (4) | ES2602956T3 (el) |
HK (4) | HK1150756A1 (el) |
PT (5) | PT1384478E (el) |
TR (2) | TR200100883T2 (el) |
TW (1) | TWI222361B (el) |
WO (1) | WO2000018386A2 (el) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6716830B2 (en) | 1998-09-30 | 2004-04-06 | Alcon, Inc. | Ophthalmic antibiotic compositions containing moxifloxacin |
US6509327B1 (en) | 1998-09-30 | 2003-01-21 | Alcon Manufacturing, Ltd. | Compositions and methods for treating otic, ophthalmic and nasal infections |
AR020661A1 (es) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento |
US6395746B1 (en) | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
DE19937116A1 (de) | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
DE19937115A1 (de) * | 1999-08-06 | 2001-02-08 | Bayer Ag | Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon |
PL201130B1 (pl) | 1999-09-24 | 2009-03-31 | Alcon Inc | Kompozycje zawiesinowe zawierające ciprofloksacynę i deksametazon do podawania miejscowego do oczu, uszu lub nosa |
DE19962470A1 (de) | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
AU2001261748A1 (en) * | 2000-05-19 | 2001-12-03 | Alcon Laboratories Inc. | Antibiotic compositions for treatment of the eye, ear and nose |
CA2412575C (en) | 2000-07-26 | 2009-12-29 | Onkar N. Singh | Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
AU2002214308A1 (en) * | 2000-11-16 | 2002-05-27 | Wakamoto Pharmaceutical Co., Ltd. | Antibacterial gel eye drops |
AU2002226926A1 (en) * | 2000-12-20 | 2002-07-01 | Alcon, Inc. | Antifungal compositions containing an antibiotic and one or more amidoamines |
US7025958B2 (en) | 2000-12-20 | 2006-04-11 | Alcon, Inc. | Use of amidoamines to treat or prevent acanthamoeba and fungal infections |
EP1429780B1 (en) | 2001-09-21 | 2005-12-21 | Alcon, Inc. | Method of treating middle ear infections |
US7220431B2 (en) | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
WO2006015545A1 (fr) * | 2004-08-11 | 2006-02-16 | Shenzhen Tys R & D Co., Ltd. | Capsule de gelatine de moxifloxacin et procede pour sa preparation |
EP1784164A4 (en) * | 2004-09-03 | 2008-07-09 | Piedmont Pharmaceuticals Llc | PROCESS FOR TRANSMEMBRANE TREATMENT AND PREVENTION OF OTITIS MEDIA |
DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
KR20070089222A (ko) * | 2004-12-10 | 2007-08-30 | 알콘, 인코퍼레이티드 | 귀 감염을 치료하기 위한 조성물 |
CN101317847B (zh) * | 2007-06-06 | 2010-10-13 | 深圳市瑞谷医药技术有限公司 | 一种眼用或耳鼻用药物组合物及其用途 |
TWI544934B (zh) * | 2008-06-09 | 2016-08-11 | 愛爾康研究有限公司 | 含有氟喹諾酮抗生素藥物之經改良藥學組成物 |
UY32758A (es) * | 2009-07-02 | 2010-10-29 | Alcon Res Ltd | Composiciones y métodos para el tratamiento de infecciones ópticas, nasales u oftálmicas |
DK2521547T3 (da) * | 2010-01-07 | 2017-11-20 | Novartis Ag | Fremgangsmåder og sammensætninger til påføring af moxifloxacin til ørene |
US9138481B2 (en) | 2011-12-06 | 2015-09-22 | Alcon Research, Ltd. | Cellulosic gel composition with improved viscosity stability |
RU2472507C1 (ru) * | 2012-02-01 | 2013-01-20 | Закрытое акционерное общество "Брынцалов-А" | Водный состав на основе моксифлоксацина для парентерального введения |
US9504691B2 (en) * | 2012-12-06 | 2016-11-29 | Alcon Research, Ltd. | Finafloxacin suspension compositions |
US20150164882A1 (en) | 2013-07-22 | 2015-06-18 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
US20160279055A1 (en) | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
CN104224802B (zh) * | 2014-09-19 | 2017-12-12 | 南京优科生物医药研究有限公司 | 一种盐酸莫西沙星滴耳剂及其制备方法 |
RU2595837C2 (ru) * | 2014-09-29 | 2016-08-27 | Открытое Акционерное Общество "Татхимфармпрепараты" | Состав и способ получения глазных капель |
TWI713618B (zh) * | 2015-10-29 | 2020-12-21 | 日商帝化製藥股份有限公司 | 外用劑 |
US20210038612A1 (en) * | 2018-04-03 | 2021-02-11 | Hyderabad Eye Research Foundation | Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics |
IT201900005280A1 (it) * | 2019-04-05 | 2020-10-05 | Ntc S R L | Composizione otologica |
JP2023530254A (ja) * | 2020-06-10 | 2023-07-14 | オキュラー サイエンス,インク. | 手術後の眼科的ケアのための組成物および方法 |
KR102656260B1 (ko) | 2022-10-14 | 2024-04-09 | 주식회사태준제약 | 목시플록사신을 포함하는 안과용 조성물 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223493A (en) | 1984-12-28 | 1993-06-29 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
CA1325382C (en) * | 1988-01-27 | 1993-12-21 | Takahiro Ogawa | Locally administrable therapeutic composition for inflammatory disease |
DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
AU4201189A (en) * | 1988-08-26 | 1990-03-23 | Alcon Laboratories, Inc. | Combination of quinolone antibiotics and steroids for topical ophthalmic use |
JPH03109236A (ja) * | 1989-09-22 | 1991-05-09 | Hoya Corp | 半導体超微粒子分散ガラスの製造方法 |
JPH085779B2 (ja) * | 1989-09-22 | 1996-01-24 | 杏林製薬株式会社 | フレロキサシン点眼液 |
TW209865B (el) * | 1992-01-10 | 1993-07-21 | Bayer Ag | |
DK0639070T4 (da) | 1992-05-06 | 2010-12-13 | Alcon Lab Inc | Anvendelse af borat-polyolkomplekser til ophtalmiske præparater |
DE4424369A1 (de) * | 1994-07-11 | 1996-01-18 | Bayer Ag | Pyrido[3,2,1.i,j][3,1]benzoxazinderivate |
JPH0892241A (ja) * | 1994-09-22 | 1996-04-09 | Ss Pharmaceut Co Ltd | 5−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤 |
US5631287A (en) | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
ES2173287T3 (es) * | 1995-06-06 | 2002-10-16 | Bayer Ag | Composiciones oticas antibacterianas no irritantes, no sensibilizantes y no ototoxicas. |
JP3290914B2 (ja) * | 1997-03-17 | 2002-06-10 | 参天製薬株式会社 | 眼組織におけるキノロン系抗菌剤の定量装置 |
IL134591A0 (en) * | 1997-09-25 | 2001-04-30 | Bayer Ag | Medicament formulation with a controlled release of an active agent |
ID28630A (id) | 1998-09-23 | 2001-06-21 | Unilever Nv | Komposisi-komposisi perawatan oral |
AR020661A1 (es) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento |
US20020001617A1 (en) * | 2000-05-26 | 2002-01-03 | Chang-Hyun Lee | Rapidly disintegrating tablet and process for the manufacture thereof |
-
1999
- 1999-09-27 AR ARP990104866A patent/AR020661A1/es not_active Application Discontinuation
- 1999-09-29 PT PT03020587T patent/PT1384478E/pt unknown
- 1999-09-29 DK DK14176366.4T patent/DK2796138T3/en active
- 1999-09-29 ES ES14176366.4T patent/ES2602956T3/es not_active Expired - Lifetime
- 1999-09-29 ES ES10178657.2T patent/ES2519190T3/es not_active Expired - Lifetime
- 1999-09-29 ES ES10176412.4T patent/ES2526521T3/es not_active Expired - Lifetime
- 1999-09-29 CN CNB2004100973271A patent/CN100374114C/zh not_active Expired - Lifetime
- 1999-09-29 PT PT141763664T patent/PT2796138T/pt unknown
- 1999-09-29 EP EP03020587A patent/EP1384478B1/en not_active Expired - Lifetime
- 1999-09-29 DK DK10176412.4T patent/DK2269602T3/en active
- 1999-09-29 TR TR2001/00883T patent/TR200100883T2/xx unknown
- 1999-09-29 EP EP10178657.2A patent/EP2301541B1/en not_active Expired - Lifetime
- 1999-09-29 EP EP14176366.4A patent/EP2796138B1/en not_active Expired - Lifetime
- 1999-09-29 KR KR1020017003377A patent/KR101463243B1/ko active IP Right Review Request
- 1999-09-29 DE DE69912972T patent/DE69912972T2/de not_active Revoked
- 1999-09-29 DK DK03020587.6T patent/DK1384478T3/da active
- 1999-09-29 PT PT101764124T patent/PT2269602E/pt unknown
- 1999-09-29 DK DK99956504T patent/DK1117401T3/da active
- 1999-09-29 PT PT101786572T patent/PT2301541E/pt unknown
- 1999-09-29 AU AU13101/00A patent/AU762827B2/en not_active Expired
- 1999-09-29 DK DK10178657.2T patent/DK2301541T3/da active
- 1999-09-29 WO PCT/US1999/022622 patent/WO2000018386A2/en active Application Filing
- 1999-09-29 JP JP2000571905A patent/JP2002525317A/ja active Pending
- 1999-09-29 CA CA002659064A patent/CA2659064A1/en not_active Abandoned
- 1999-09-29 TR TR2007/04370T patent/TR200704370T2/xx unknown
- 1999-09-29 EP EP10176412.4A patent/EP2269602B1/en not_active Expired - Lifetime
- 1999-09-29 CA CA002342211A patent/CA2342211C/en not_active Expired - Lifetime
- 1999-09-29 AT AT03020587T patent/ATE501732T1/de active
- 1999-09-29 CA CA2774207A patent/CA2774207A1/en not_active Abandoned
- 1999-09-29 AT AT99956504T patent/ATE254458T1/de not_active IP Right Cessation
- 1999-09-29 EP EP99956504A patent/EP1117401B1/en not_active Revoked
- 1999-09-29 BR BRPI9914151-5A patent/BRPI9914151B1/pt not_active IP Right Cessation
- 1999-09-29 CN CNB998115096A patent/CN1184968C/zh not_active Ceased
- 1999-09-29 ES ES99956504T patent/ES2207307T3/es not_active Expired - Lifetime
- 1999-09-29 PT PT99956504T patent/PT1117401E/pt unknown
- 1999-09-29 DE DE69943287T patent/DE69943287D1/de not_active Expired - Lifetime
- 1999-11-03 TW TW088116726A patent/TWI222361B/zh not_active IP Right Cessation
-
2002
- 2002-01-02 HK HK11104778.7A patent/HK1150756A1/xx not_active IP Right Cessation
- 2002-01-02 HK HK11104892.8A patent/HK1150769A1/xx not_active IP Right Cessation
- 2002-01-02 HK HK04102444.4A patent/HK1059572A1/xx unknown
- 2002-01-02 HK HK02100003.3A patent/HK1038691B/zh not_active IP Right Cessation
-
2008
- 2008-08-22 JP JP2008213954A patent/JP2009007375A/ja not_active Withdrawn
-
2011
- 2011-04-21 CY CY20111100409T patent/CY1111404T1/el unknown
- 2011-05-12 AR ARP110101646A patent/AR081393A2/es not_active Application Discontinuation
-
2012
- 2012-01-10 JP JP2012002159A patent/JP2012067141A/ja not_active Withdrawn
- 2012-11-02 JP JP2012242519A patent/JP5563041B2/ja not_active Expired - Lifetime
-
2014
- 2014-05-19 JP JP2014103658A patent/JP2014144982A/ja active Pending
- 2014-10-09 CY CY20141100819T patent/CY1115759T1/el unknown
-
2015
- 2015-01-09 CY CY20151100023T patent/CY1115916T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1115916T1 (el) | Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου | |
ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
ES2170102T3 (es) | Aminociclohexilesteres y utilizacion de los mismos. | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
ES2170252T3 (es) | Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde. | |
BR9710737A (pt) | Pentafluorobenzenosulfonamidas e análogos. | |
TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
EE03969B1 (et) | (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid | |
CY1105834T1 (el) | Χρηση παρασκευασματων για την εφαρμογη, στον κατω αναπνευστικο σωληνα αντισηπτικων παραγοντων και/ή παραγοντων που προαγουν την επουλωση των πληγων | |
CY1110521T1 (el) | Υποκατεστημενα ινδολια για τη διαμορφωση της nfkb-ενεργοτητας | |
AR010062A1 (es) | Nuevos benzamidaldehidos y su utilizacion | |
ES2133785T3 (es) | Inhibidores de metaloproteinasas. | |
SE9504661D0 (sv) | New compounds | |
NO304884B1 (no) | 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav | |
DK0944643T3 (da) | Oxyiminopregnancarbolactoner. | |
PT1005453E (pt) | Compostos de benzeno substituido como agentes de reducao antiproliferativa | |
CA2339384A1 (en) | Improved method for targeted topical treatment of disease | |
NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
EE9900450A (et) | Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine | |
DK0869965T3 (da) | Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler | |
TR200103457T2 (tr) | 4-Fenil-Pirimidin Türevleri. | |
PT1109560E (pt) | Compostos uteis como inidores de aicarft | |
ES2135722T3 (es) | 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina. | |
DK0773782T3 (da) | Terpenderivater (sarcodictyiner) anvendelse som antitumormidler | |
ES2140672T3 (es) | Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos. |